Clinical Trials in Michigan

Showing 1961-1980 of 7,755 trials

Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery

NCT07009340

This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.

Post-discharge Outcomes

Renibus Therapeutics, Inc.200 participantsStarted Nov 2023

Huntsville, Alabama, United States • Fort Wayne, Indiana, United States • Midland, Michigan, United States +1 more locations

Active Not RecruitingPhase 230 miles

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NCT04533451

This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with or without chemotherapy may shrink the tumor in older patients with non-small cell lung cancer.

Metastatic Lung AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Adenocarcinoma+4 more

Alliance for Clinical Trials in Oncology101 participantsStarted Nov 2020

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +502 more locations

Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Find Trials by Condition in Michigan

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Efficacy-Implementation Study for PC CARES in Rural Alaska

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

ALL Adult Consortium Trial: Adult ALL Trial

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.